Page last updated: 2024-08-24

ibandronic acid and Hot Flashes

ibandronic acid has been researched along with Hot Flashes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Budischewski, K; du Bois, A; Jackisch, C; Kaufmann, M; Loibl, S; Lux, MP; Maass, N; Nestle-Kraemling, C; Paepke, S; Schmutzler, R; Vescia, S; von Minckwitz, G; Wallwiener, D	1

Trials

1 trial(s) available for ibandronic acid and Hot Flashes

Article	Year
The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011, Volume: 20, Issue:10 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Feasibility Studies; Female; Goserelin; Hot Flashes; Humans; Ibandronic Acid; Mass Screening; Middle Aged; Premenopause; Prognosis; Risk Factors	2011

Article

Year

The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011, Volume: 20, Issue:10

Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Feasibility Studies; Female; Goserelin; Hot Flashes; Humans; Ibandronic Acid; Mass Screening; Middle Aged; Premenopause; Prognosis; Risk Factors

2011